Perkins Adelene Q
Director at INFINITY PHARMACEUTICALS, INC.
- Sold, on record
- $2.3M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Sep 12, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- INFINITY PHARMACEUTICALS, INC.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not statedMar 5, 2015 2015
Sold 25,000 shares at $16.50 ($413k)
Perkins Adelene Q, President & CEO
Sold 5.8% of holdings ($7.1M position)404,432 shares leftFiling
- 2 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not statedMar 16, 2015 +11 days
Sold 20,000 shares at $16.00 ($320k)
Perkins Adelene Q, President & CEO
Sold 4.9% of holdings ($6.5M position)384,432 shares left0.8x usual sizeFiling
- 3 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not statedMay 14, 2015 +59 days
Sold 10,000 shares at $12.18 ($122k)
Perkins Adelene Q, President & CEO
Sold 2.6% of holdings ($4.7M position)374,432 shares left0.4x usual sizeFiling
- 4 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not statedMay 27, 2015 +13 days
Sold 10,000 shares at $12.81 ($128k)
Perkins Adelene Q, President & CEO
Sold 2.7% of holdings ($4.8M position)364,432 shares left0.5x usual sizeFiling
- 5 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not statedJun 25, 2015 +29 days
Sold 5,000 shares at $10.93 ($55k)
Perkins Adelene Q, President & CEO
Sold 1.4% of holdings ($4M position)359,432 shares left0.3x usual sizeFiling
- 6 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not statedMar 5, 2018 +984 days
Sold 5,000 shares at $2.78 ($14k)
Perkins Adelene Q, Chief Executive Officer
Sold 0.8% of holdings ($1.7M position)607,252 shares leftFirst sale on recordFiling
- 7 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not statedOct 1, 2018 +210 days
Sold 5,000 shares at $2.82 ($14k)
Perkins Adelene Q, Chief Executive Officer
Sold 0.8% of holdings ($1.7M position)609,561 shares leftFiling
- 8 Form 4 sale INFINITY PHARMACEUTICALS, INC.RoutineSep 12, 2023 +1807 days
Sold 410,196 shares at $0.0700 ($29k)
Perkins Adelene Q, Director
10b5-1 planSold 25.9% of holdings ($111k position)1.2M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 | Sep 12, 2023 | INFINITY PHARMACEUTICALS, INC. | Director | Form 4 sale | 410,196 | $29k | 25.9% | Routine | SEC |
| Oct 1, 2018 | Oct 2, 2018 | INFINITY PHARMACEUTICALS, INC. | Chief Executive Officer | Form 4 sale | 5,000 | $14k | 0.8% | Plan not stated | SEC |
| Mar 5, 2018 | Mar 7, 2018 | INFINITY PHARMACEUTICALS, INC. | Chief Executive Officer | Form 4 sale | 5,000 | $14k | 0.8% | Plan not stated | SEC |
| Jun 25, 2015 | Jun 26, 2015 | INFINITY PHARMACEUTICALS, INC. | President & CEO | Form 4 sale | 5,000 | $55k | 1.4% | Plan not stated | SEC |
| May 27, 2015 | May 28, 2015 | INFINITY PHARMACEUTICALS, INC. | President & CEO | Form 4 sale | 10,000 | $128k | 2.7% | Plan not stated | SEC |
| May 14, 2015 | May 15, 2015 | INFINITY PHARMACEUTICALS, INC. | President & CEO | Form 4 sale | 10,000 | $122k | 2.6% | Plan not stated | SEC |
| Mar 16, 2015 | Mar 17, 2015 | INFINITY PHARMACEUTICALS, INC. | President & CEO | Form 4 sale | 20,000 | $320k | 4.9% | Plan not stated | SEC |
| Mar 5, 2015 | Mar 9, 2015 | INFINITY PHARMACEUTICALS, INC. | President & CEO | Form 4 sale | 25,000 | $413k | 5.8% | Plan not stated | SEC |
| Jan 29, 2015 | Feb 2, 2015 | INFINITY PHARMACEUTICALS, INC. | President & CEO | Form 4 sale | 20,000 | $297k | 4.5% | Plan not stated | SEC |
| Sep 13, 2013 | Sep 13, 2013 | INFINITY PHARMACEUTICALS, INC. | Pres & Chief Executive Officer | Form 4 sale | 45,000 | $932k | 9.1% | Plan not stated | SEC |